You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 香雪製藥連續兩日漲停 料2019年淨利潤同比增長40%-70%
格隆匯 01-21 13:26
格隆匯1月21日丨香雪製藥(300147.SZ)漲停,封單逾9萬手,已連續兩日漲停,現報10.73元,暫成交3.2億元,最新總市值71億元。香雪製藥前日(19日)晚間曾發公告稱,預計2019年實現淨利潤7901.50萬元~9594.68萬元,同比增長40%-70%。報告期內,公司中成藥和中藥飲片的業務收入及利潤較上年同期取得了較快增長;進一步提升了運營效率,優化了資產與負債結構,期間費用較上年同期有所下降;預計非經常性損益對淨利潤的影響金額約8000萬元人民幣,主要包括取得處置子公司股權轉讓收益與政府補助收入等。此外據悉,香雪製藥昨晚已連夜籌備200件總價值為28萬元的抗病毒口服液,作為義捐物資支援武漢抗擊新型冠狀病毒一線。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account